199 related articles for article (PubMed ID: 36269884)
21. Impact of percutaneous femoral arteriotomy closure using the MANTA
De Palma R; Settergren M; Rück A; Linder R; Saleh N
Catheter Cardiovasc Interv; 2018 Nov; 92(5):954-961. PubMed ID: 29575678
[TBL] [Abstract][Full Text] [Related]
22. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
Barbash IM; Barbanti M; Webb J; Molina-Martin De Nicolas J; Abramowitz Y; Latib A; Nguyen C; Deuschl F; Segev A; Sideris K; Buccheri S; Simonato M; Rosa FD; Tamburino C; Jilaihawi H; Miyazaki T; Himbert D; Schofer N; Guetta V; Bleiziffer S; Tchetche D; Immè S; Makkar RR; Vahanian A; Treede H; Lange R; Colombo A; Dvir D
Eur Heart J; 2015 Dec; 36(47):3370-9. PubMed ID: 26314688
[TBL] [Abstract][Full Text] [Related]
23. Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
van Wiechen MP; Kroon H; Hokken TW; Ooms JF; de Ronde-Tillmans MJ; Daemen J; de Jaegere PP; Van Mieghem NM
Catheter Cardiovasc Interv; 2021 Nov; 98(5):E737-E745. PubMed ID: 33533544
[TBL] [Abstract][Full Text] [Related]
24. Vascular Complications Among Patients Undergoing Trans-femoral Transcatheter Aortic Valve Implantation: Prostar
Marcusohn E; Qasum M; Epstein D; Solomonica A; Orbach A; Musallam A; Kerner A; Feld Y
Angiology; 2022 Aug; 73(7):635-642. PubMed ID: 35147041
[TBL] [Abstract][Full Text] [Related]
25. Single versus double use of a suture-based closure device for transfemoral aortic valve implantation.
Reifart J; Liebetrau C; Weferling M; Dörr O; Renker M; Bhumimuang K; Liakopoulos O; Choi YH; Nef H; Hamm CW; Kim WK
Int J Cardiol; 2021 May; 331():183-188. PubMed ID: 33529662
[TBL] [Abstract][Full Text] [Related]
26. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
[TBL] [Abstract][Full Text] [Related]
27. Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation.
Gmeiner JMD; Linnemann M; Steffen J; Scherer C; Orban M; Theiss H; Mehilli J; Sadoni S; Peterß S; Joskowiak D; Hagl C; Tsilimparis N; Curta A; Maurus S; Doldi PM; Löw K; Haum M; Roden D; Hausleiter J; Massberg S; Rizas K; Deseive S; Braun D
EuroIntervention; 2022 Nov; 18(10):812-819. PubMed ID: 35903846
[TBL] [Abstract][Full Text] [Related]
28. The novel echo-guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation.
Honda Y; Araki M; Yamawaki M; Tokuda T; Tsutumi M; Mori S; Sakamoto Y; Kobayashi N; Hirano K; Ito Y
J Interv Cardiol; 2018 Apr; 31(2):216-222. PubMed ID: 29193337
[TBL] [Abstract][Full Text] [Related]
29. Comparison of percutaneous closure systems for large bore vascular access sites in endovascular procedures.
Košak L; Lulić D; Jakljević T; Gobić D; Aničić J; Tomulić V
Front Cardiovasc Med; 2023; 10():1130627. PubMed ID: 37089885
[TBL] [Abstract][Full Text] [Related]
30. Incidence, Prognosis and Predictors of Major Vascular Complications and Percutaneous Closure Device Failure Following Contemporary Percutaneous Transfemoral Transcatheter Aortic Valve Replacement.
Batchelor W; Patel K; Hurt J; Totten J; Burroughs P; Smith G; Cuervo M; Davis L; Damluji AA; Epps K; Sherwood M; Barnett S; Geloo N; Yazdani S; Sarin E; Ryan L; Noel T
Cardiovasc Revasc Med; 2020 Sep; 21(9):1065-1073. PubMed ID: 31974033
[TBL] [Abstract][Full Text] [Related]
31. Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation.
Barbanti M; Capranzano P; Ohno Y; Gulino S; Sgroi C; Immè S; Tamburino C; Cannata S; Patanè M; Di Stefano D; Todaro D; Di Simone E; Deste W; Gargiulo G; Capodanno D; Grasso C; Tamburino C
EuroIntervention; 2015 Oct; 11(6):690-7. PubMed ID: 26499222
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study.
Boussofara A; Godin M; Canville A; Baala B; Berland J; Koning R; Landolff Q
Catheter Cardiovasc Interv; 2024 Mar; 103(4):650-659. PubMed ID: 38407552
[TBL] [Abstract][Full Text] [Related]
33. Trends in vascular complications and associated treatment strategies following transfemoral transcatheter aortic valve replacement.
Ullery BW; Jin R; Kirker EB; Hayes G; Siwek L; Brevig J; Hodson RW; Spinelli KJ
J Vasc Surg; 2020 Oct; 72(4):1313-1324.e5. PubMed ID: 32169358
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Posttranscatheter Aortic Valve Implantation Vascular Complications in Real Life.
Matta A; Canitrot R; Nader V; Bouisset F; Lhermusier T; Campelo-Parada F; Grunenwald E; Marcheix B; Elbaz M; Carrie D; Roncalli J
J Interv Cardiol; 2021; 2021():5563486. PubMed ID: 34729054
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of ProGlide versus MANTA vascular closure devices for large-bore access site management.
Mahalwar G; Shariff M; Datla S; Agrawal A; Rathore SS; Arif TB; Iqbal K; Hussain N; Majmundar M; Kumar A; Kalra A
Indian Heart J; 2022; 74(3):251-255. PubMed ID: 35367458
[TBL] [Abstract][Full Text] [Related]
36. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S
EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140
[TBL] [Abstract][Full Text] [Related]
37. Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications.
Masiero G; D'Angelo L; Fovino LN; Fabris T; Cardaioli F; Rodinò G; Benedetti A; Boiago M; Continisio S; Montonati C; Sciarretta T; Zuccarelli V; Scotti A; Lorenzoni G; Pavei A; Napodano M; Fraccaro C; Iliceto S; Marchese A; Esposito G; Tarantini G
Front Cardiovasc Med; 2022; 9():832242. PubMed ID: 35295263
[TBL] [Abstract][Full Text] [Related]
38. Femoral Arterial Calcification and Plug- vs. Suture-Based Closure Device Strategies Post-Transcatheter Aortic Valve Implantation: Insights From CHOICE-CLOSURE.
Fitzgerald S; Dumpies O; Shibata M; Hartung P; Obradovic D; Boekstegers P; Vorpahl M; Rotta Detto Loria J; Kiefer P; Desch S; Thiele H; Abdel-Wahab M
Struct Heart; 2024 Mar; 8(2):100236. PubMed ID: 38481717
[TBL] [Abstract][Full Text] [Related]
39. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
[TBL] [Abstract][Full Text] [Related]
40. Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide.
Hoffmann P; Al-Ani A; von Lueder T; Hoffmann J; Majak P; Hagen O; Loose H; Kløw NE; Opdahl A
CVIR Endovasc; 2018; 1(1):20. PubMed ID: 30652151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
